🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07502209
Recruiting Not applicable

Notch vs Midpoint Suprascapular Nerve PRF for Chronic Shoulder Pain

NCT07502209 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-05-07
Last updated
2026-06-30

Condition(s) studied

Chronic Shoulder PainRotator Cuff Tendinopathy

Investigational drug(s) / intervention(s)

PRF of the Suprascapular Nerve (Notch Approach)PRF of the Suprascapular Nerve (Midpoint Approach)

PRF of the Suprascapular Nerve (Notch Approach): Under ultrasound guidance, a radiofrequency needle will be positioned adjacent to the suprascapular nerve at the suprascapular notch. Sensory stimulation at 50 Hz and motor stimulation at 2 Hz will be performed to confirm appropriate needle placement. Pulsed radiofrequency will then be applied at 42°C for three cycles of 120 seconds.

PRF of the Suprascapular Nerve (Midpoint Approach): Under ultrasound guidance, a radiofrequency needle will be positioned adjacent to the suprascapular nerve at the midpoint between the suprascapular notch and the spinoglenoid notch. Sensory stimulation at 50 Hz and motor stimulation at 2 Hz will be performed to confirm appropriate needle placement. Pulsed radiofrequency will then be applied at 42°C for three cycles of 120 seconds.

Study summary

This study aims to compare the effects of pulsed radiofrequency (PRF) treatment of the suprascapular nerve using suprascapular notch and midpoint approaches on pain, shoulder function, and muscle strength in patients with chronic shoulder pain due to rotator cuff tendinopathy. Patients will be randomly assigned to one of the two intervention groups. Clinical evaluations will include pain assessment using the Numeric Rating Scale (NRS), functional assessment using the Shoulder Pain and Disability Index (SPADI), and quality of life assessment using the Short Form-36 (SF-36). In addition, shoulder range of motion will be measured goniometrically, muscle thickness of the supraspinatus and infraspinatus will be evaluated by ultrasonography, and shoulder muscle strength will be assessed using an isokinetic dynamometer. Assessments will be performed at baseline, 24 hours, 1 month, and 3 months after the intervention. The results of this study are expected to provide evidence regarding the optimal approach for PRF treatment of the suprascapular nerve in patients with chronic shoulder pain.

Eligibility

Sex
ALL
Min age
40 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Patients aged between 40 and 80 years * Patients with chronic shoulder pain lasting longer than 3 months * Patients diagnosed with rotator cuff-related shoulder pain * Patients who show at least 50% pain reduction after diagnostic suprascapular nerve block * Patients who provide written informed consent Exclusion Criteria: * Adhesive capsulitis * Previous shoulder surgery * Full-thickness rotator cuff tear * Neurological disorders affecting the shoulder * Pacemaker * Coagulopathy or anticoagulant therapy contraindicating intervention * Infection at the injection site * Severe systemic disease * Pregnancy * Inability to comply with study protocol

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ankara Bilkent City Hospital Ankara Turkey (Türkiye) Recruiting

More Ankara City Hospital Bilkent trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07502209 on ClinicalTrials.gov ↗ ← All trials in Turkey